ARCHIVES

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

This article is from The Cancer Letter archive.

Vol. 12 No. 14 | April 4, 1986

Download PDF Visit The Full Archive

Related Articles

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

Trials Approved by NCI CTEP Last Month

November 25, 2011

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013